| BRIEF RESEARCH ARTICLE |
|
| Year : 2022 | Volume
: 66
| Issue : 4 | Page : 494-497 |
|
|
Risk factors for severe rhino-orbital mucormycosis during its epidemic post-COVID-19 pandemic
Gopal Krushna Das1, Ankur Singh2, Nitika Beri3, Pramod Kumar Sahu1, Tanya Bisht4, Isha Sharma3
1 Director Professor, Department of Ophthalmology, University College of Medical Sciences and GTB Hospital, Delhi, India
2 Assistant Professor, Department of Ophthalmology, University College of Medical Sciences and GTB Hospital, Delhi, India
3 Senior Resident, Department of Ophthalmology, University College of Medical Sciences and GTB Hospital, Delhi, India
4 Resident, Department of Ophthalmology, University College of Medical Sciences and GTB Hospital, Delhi, India
Correspondence Address:
Nitika Beri
E-417, Aastha Kunj, Rohini Sector-18, Delhi-110 089
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ijph.ijph_714_22
|
|
|
Postsecond wave of COVID-19 pandemic in the year 2021, rhino-orbital mucormycosis (ROM) was seen as an epidemic in the Indian community. Severe ROM disease has poor prognosis and requires a multidisciplinary approach for treatment. Hence, its prevention is better than cure. Studies done during the epidemic assessed predisposing factors, but this was a novel study which focused on assessing risk factors for severe disease of ROM. Ninety-four consecutive patients of ROM admitted at our designated nodal tertiary hospital of North India were enrolled, and data were collected and analyzed. Facial edema was the most common presenting complaint. Subclinical and mild COVID-19 infection was associated with severe ROM. Uncontrolled diabetes mellitus and prophylactic zinc supplementation were other significant risk factors for severe ROM. Public awareness among the general population for the above risk factors can prevent a debilitating disease like severe ROM.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
